A comprehensive view of United Therapeutics Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Patent Application Titled 'Treatment Of Vasculopathy With Prostacyclin And Mesenchymal Stem Cells' Published Online (USPTO 20240100003)
Published: April 17, 2024 by Heart Disease Daily
Australia Patent: UNITED THERAPEUTICS Files Application for 'SYSTEMS AND METHODS FOR TISSUE EVALUATION'
Published: April 05, 2024 by Australian Government
United Therapeutics Corporation - Material Agreement - Form 8-K
Published: March 29, 2024 by U.S. Markets (Alternative Disclosure) via PUBT
UNITED THERAPEUTICS CORP - (8-K) - Disclosing Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Published: March 29, 2024 by SEC Edgar Filings
UNITED THERAPEUTICS CORP - (8-K) - Disclosing Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Published: March 25, 2024 by SEC Edgar Filings

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count